Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LENSAR, Inc. - Common Stock (NQ: LNSR )

11.85 +2.38 (+25.08%)
Streaming Delayed Price Updated: 2:23 PM EST, Feb 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 212,029
Open 9.780
Bid (Size) 11.77 (1)
Ask (Size) 11.98 (10)
Prev. Close 9.470
Today's Range 9.780 - 12.63
52wk Range 2.670 - 12.13
Shares Outstanding 11,102,611
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire

Performance

YTD
+36.31%
+36.31%
1 Month
+10.70%
+10.70%
3 Month
+54.03%
+54.03%
6 Month
+153.64%
+153.64%
1 Year
+139.29%
+139.29%

More News

Read More
LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
From LENSAR, Inc.
Via Business Wire
3 Under-$10 Stocks With the Potential to Make You a Millionaire
Via InvestorPlace
Earnings Preview: LENSAR
Via Benzinga
LENSAR's Earnings Outlook
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Participate in Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LNSR Stock Earnings: LENSAR Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
From LENSAR, Inc.
Via Business Wire
LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
LENSAR Reports First Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Earnings Scheduled For March 4, 2024
Via Benzinga
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
From LENSAR, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.